Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studies

Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studies

Gary T Ferguson,1 Gregory J Feldman,2 Peter Hofbauer,3 Alan Hamilton,4 Lisa Allen,5 Lawrence Korducki,5 Paul Sachs6 1Pulmonary Research Institute of Southeast Michigan, Livonia, MI, 2S Carolina Pharmaceutical Research, Spartanburg, SC, USA; 3Pneumologie, Weinheim, Germany; 4Boehringer Ingelheim, Bu...

Full description

Bibliographic Details
Main Authors: Ferguson GT, Feldman GJ, Hofbauer P, Hamilton A, Allen L, Korducki L, Sachs P
Format: Article
Language:English
Published: Dove Medical Press 2014-06-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/efficacy-and-safety-of-olodaterol-once-daily-delivered-via-respimatreg-a17214

Internet

http://www.dovepress.com/efficacy-and-safety-of-olodaterol-once-daily-delivered-via-respimatreg-a17214

Similar Items